Skip to content

Auto positive airway pressure for obstructive sleep apnoea

Auto PAP: its effectiveness in reducing the apnoea hypopnoea index in severe obstructive sleep apnoea

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12608000184370
Enrollment
12
Registered
2008-04-10
Start date
2008-03-15
Completion date
2008-11-01
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Study aims to determine whether autoPAP technology is suitable for patients requiring a high treatment pressure to treat obstructive sleep apnoea. The study found that this was very variable with some patients being well treated and others not.

Interventions

Crossover trial of AutoPAP and CPAP for a period of 4 nights with a 4 night washout

Sponsors

University of Otago
Lead SponsorUniversity

Study design

Allocation
Randomised controlled trial
Intervention model
Crossover
Primary purpose
Treatment
Masking
Blinded (masking used)

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

Patients with severe OSA and either BMI > 40kg/m2 or neck circumference> 48cm plus a need for a manually titrated CPAP pressure of >= 14cmH2O to prevent 95% of OSA

Exclusion criteria

Another sleep disorder Cardiac or respiratory failure Poor comprehension of English

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026